(Credit-Canva)
We have all seen movies where right before the hero starts fighting, he cracks his knuckles and makes it look like the coolest thing in the world! But then our parents told us that you should not crack your knuckles because that weakens your grip and hand strength. But is that true? While many people do say that they experience a small loss in strength immediately after they crack their knuckles, but are their long-term effects to it? And what is the sound actually coming from?
The reason why people crack their fingers is because the evident and sharp crack noise causes a sense of relief. Many people also do it when they have done an activity that required them to work with their hands a lot like typing or sewing, giving themselves a sense of satisfaction, similar to stretching after doing hard work. That "crack" sound can make some people cringe, while others find it strangely satisfying. Cracking your knuckles is a pretty common habit, but there are a lot of misunderstandings about it. Some people do it without even thinking, others can't stand the noise, and some can't crack their knuckles at all. You might have been told as a kid that it causes arthritis or makes your fingers swell up. But those are just old wives' tales. There's a real science behind this habit, and it's more interesting than you may think.
The "crack" isn't actually bones breaking or anything bad happening to your joints. It's a normal thing called "crepitus." This just means harmless popping, snapping, or grinding sounds that come from your joints. The main reason you hear this sound is because of gas bubbles in the fluid that cushions your joints. This fluid is called synovial fluid. When you move or stretch, these tiny bubbles form and then pop, making the sound. It's totally normal and doesn't hurt you. Sometimes, especially in bigger joints like your knees, shoulders, or ankles, the sound can also happen when the stretchy tissues that connect your bones (ligaments and tendons) move slightly and then snap back into place.
After you crack your knuckles, you can't usually do it again right away. You have to wait a bit. That's because the gas bubbles in your joint fluid have already popped, and it takes a little while for them to build up again. While cracking your knuckles doesn't give you arthritis, doing it too much might cause some problems. Doctors say that cracking them too often could make your joints a little wobbly and might even make your grip weaker. Also, if the stretchy tissues in your joints keep snapping over your bones, they can get irritated and sore.
Sometimes, a pop in your joint is just like cracking your knuckles, nothing to worry about. But other times, it can be a sign of something else. As we get older, the cushiony stuff in our joints, called cartilage, can start to wear down. This cartilage helps your bones move smoothly. When it gets thin or uneven, the bones can rub together, and that can make a grinding or popping sound. This is different from the pop you get from gas bubbles. If this grinding sound happens along with pain, it could be a sign of osteoarthritis. This is a type of joint problem that's more common in older people, but younger people can get it too, especially after a joint injury. If your joints hurt, especially in the morning or after you've been sitting still for a while, feel wobbly, or are hard to move, it's a good idea to see a doctor.
Credit: AI generated image
Higher temperatures in the US could increase heat-related heart disease by 200 per cent by 2050, according to an alarming study.
The research, published in JAMA Cardiology, predicts rising temperatures driven by climate change will dramatically increase heat-related heart disease in the US.
It is already known that extreme heat is detrimental to heart health and can potentially trigger heart attacks and other cardiovascular events.
"But this study is the first to map out exactly how bad the problem could get—county by county, across the US. It also highlighted how states with lower median household incomes are likely to face higher heat-related heart disease burden," said Gokul Parameswaran, research associate at the Case Western Reserve School of Medicine's Cardiovascular Research Institute and the study's lead author.
Researchers analyzed heart disease data in each county in the contiguous US from 2010 to 2016 to develop projections through 2050.
They found that the Pacific Northwest has the highest heat-related heart disease rate in the country. Southern states, however, are projected to see the steepest increases by 2050.
"Climate change is not just an environmental issue—it is a health equity crisis, and prioritizing vulnerable communities must be at the center of any heat mitigation strategy," said Salil Deo, associate professor in the Department of Surgery.
Also read: Global Temperatures Likely To Stay Near Record Levels For Next Five Years: WMO
The study also found that aging — independent of temperature increases — will contribute an additional 34 per cent increase in heat-related heart disease by 2050, simply because there will be more older adults by then.
The study comes amidst more frequent heat events in the US, which is also lasting longer, and the temperatures during heat events are going up.
The past 10 years, from 2015 to 2024, were the hottest on record globally. But in cities across the United States, the average rate of extreme heat events increased from two per year in the 1960s to 10 per year between 2010 and 2020, according to Center for Climate and Energy Solutions (C2ES), a Washington-based NGO.
Also Read:‘Heat Dome’ Triggering Record-Breaking May Temperatures In France, UK, Spain
Additionally, as of 2024, the average length of heat-wave season in the US has increased by 46 days since the 1960s.
According to the Centers for Disease Control and Prevention, when temperatures rise, the heart must work harder to keep the body cool, and the likelihood of developing sudden clots in the bloodstream increases.
Read More: Can Extreme Heat Trigger Heart Palpitations? Expert Explains Risks
This extra stress on the heart due to high heat may lead to heart attacks or sudden worsening of heart disease, especially in the elderly or those with prior heart conditions.
"Climate change is not a distant, abstract threat," said Sanjay Rajagopalan, director of the Cardiovascular Research Institute and chief of Cardiovascular Medicine at University Hospitals Harrington Heart & Vascular Institute.
"It is a present and growing danger to the hearts of every American, and it is coming for the most vulnerable among us first. The choices made today about greenhouse gas emissions, urban planning, and health care policy will determine whether tens of thousands of Americans live or die from heat-related heart disease by 2050," he added.
Credit: iStock
Diabetes is not only a disorder affecting blood sugar levels, but it also increases the risk of heart disease. People who have diabetes are more prone to get affected by heart attack, stroke, high blood pressure, and blockage of arteries than people without diabetes. Because of this strong link, diabetes care needs a focus on both blood sugar control and heart care.
One of the biggest improvements in diabetes care is the use of GLP-1 receptor agonist therapies. These medications not only help to control sugars but also reduce the risk of heart disease. When a person combines GLP-1 treatment along with a healthy lifestyle, they can improve their overall well-being and lead a good quality of life.
Type 2 diabetes and heart disease are interlinked. Diabetes increases heart disease risk by 2 to 4 times. Over a period of time, when the sugars are chronically high, blood vessels and nerves that support the heart get damaged. Many individuals with diabetes also have additional risk factors, such as:
These conditions can make a person vulnerable to a heart attack and stroke. Studies show that people with Type 2 diabetes are nearly twice as likely to develop heart disease compared to those without diabetes.
GLP-1 receptor agonists are medications to control high blood sugar in people with type 2 diabetes. These therapies help by:
GLP-1 therapies help control blood sugar. Beyond this, these treatment regimens provide many more benefits. Research shows that these medications can reduce the risk of major cardiovascular events such as heart attack and stroke.
In addition, GLP-1 therapies help in weight reduction. Obesity is also linked to diabetes and heart disease. Hence, GLP-1 therapies help to reduce weight and the risk of developing heart diseases.
Medications are important in controlling blood sugars. However, the medication therapies need to be combined with a healthy lifestyle, which can remain the foundation of diabetes and heart disease care.
A balanced, healthy plate can improve blood sugar, cholesterol, and blood pressure levels. Individuals with diabetes are encouraged to include:
Whole grains
Vegetables and fruits
Lean proteins
Nuts and seeds
Healthy fats
By restricting sugars, processed and ultra-processed foods, extra salt, and unhealthy trans-fats, one can reduce weight and support heart health.
Regularized physical activity routines help improve insulin sensitivity and strengthen the heart. Activities like walking, cycling, swimming, yoga, and strength training can help reduce the risk of heart disease. Experts generally recommend at least 150 minutes of moderate exercise every week.
Even small amounts of weight loss can improve blood sugar control and reduce stress on the heart. The combination of GLP-1 therapies, healthy lifestyle, controlled eating, and regular exercise gives better long-term results.
Type 2 diabetes and heart disease are closely interlinked, making complete diabetes care essential. GLP-1 therapies are changing diabetes management by offering benefits beyond glycemic control, including heart protection and weight reduction.
However, tablets and medicines alone cannot do all the work. Healthy lifestyle changes, such as balanced nutrition, regular physical activity, and proper weight management, must contribute equally. GLP-1 therapies and lifestyle changes can significantly reduce heart-related risks and improve overall well-being in individuals with Type 2 diabetes.
Credit: iStock
Multiple Sclerosis (MS) is a chronic neurological condition in which the immune system attacks the central nervous system, leading to symptoms such as fatigue, chronic pain, bladder disturbances, gait imbalance, and blurry vision, among others. These symptoms fluctuate, progress over time, become life-limiting, and are not always outwardly visible.
Growing evidence shows that early diagnosis and timely initiation of high-efficacy therapies (HETs) can slow disease progression, reduce relapses, and preserve long-term neurological function. For many individuals living with MS, the struggle goes beyond simply managing their condition. It is also about whether the full impact of the disease is adequately recognized and understood by policymakers, healthcare systems, and the public at large.
Although MS is recognized as a disability under the Rights of Persons with Disabilities (RPwD) Act, 2016, people living with MS (PwMS) continue to face difficulties accessing disability-related support because their symptoms are not always consistent, visible, or measurable during assessment. This is particularly relevant in a condition like MS, where some of the most disabling symptoms remain invisible.
The effects of MS extend far beyond mobility issues alone. Fatigue, brain fog, memory problems, neuropathic pain, bladder dysfunction, visual disturbances, and emotional strain can significantly hinder a person's ability to work, engage socially, manage responsibilities, and fully participate in everyday activities.
One of the less understood aspects of MS is cognitive impairment, which affects a significant proportion of PwMS. MS causes inflammation in the brain and contributes to brain volume loss, thereby slowing processing speed, affecting concentration, impairing memory, and making planning or multitasking increasingly difficult. Even routine activities such as maintaining conversations, remembering instructions, or completing everyday tasks may become mentally exhausting.
Because many of these symptoms are episodic, variable, or invisible, PwMS may sometimes delay seeking specialist care, while the impact of the disease may also be underestimated by those around them. Yet, MS disease activity can continue even when symptoms appear intermittent or mild.
In MS, treatment decisions regarding the early initiation of the appropriate therapy (platform disease-modifying therapy versus high-efficacy therapy) can meaningfully influence long-term outcomes and quality of life.
Because slowing disease progression often requires highly potent intervention, evaluating a drug’s long-term safety profile becomes just as critical as its efficacy. Certain therapies may carry a risk of progressive multifocal leukoencephalopathy (PML)—a rare and potentially fatal viral brain infection that occurs under severe immunosuppression. Therefore, choosing a high-efficacy treatment with a favorable long-term safety profile is paramount.
MS is inherently unpredictable. A person may appear physically stable during one evaluation but experience significant neurological difficulties during a relapse or disease flare-up.
In clinical practice, neurologists evaluate MS through disease progression, relapse patterns, imaging findings, and the EDSS scale (a standardized method used to quantify and measure the level of disability in PwMS).
Improving understanding of invisible symptoms in MS is important not only for social awareness but also for enabling patients to access timely care. Greater clarity, consistency, and sensitivity in approaches to chronic neurological conditions can help ensure that PwMS are better supported across healthcare, workplace, and social settings.
Earlier diagnosis, timely intervention, and stronger recognition of the day-to-day realities of living with MS can together help patients preserve dignity, maintain independence, and achieve better long-term outcomes.
© 2024 Bennett, Coleman & Company Limited